MKI67 and neoplasm: In support of the above study, our xenograft model showed higher uptake of tumor (higher number of xenografts successfully established) in NIC-treated animals in contrast to vehicle-treated mice, which corroborated with our in vitro data, suggesting that NIC provides survival advantage to the cancer cells by increasing the rate of proliferation (higher Ki67 positive, high MTT reading in vitro).